AGREEing on Clinical Practice Guidelines for Autism Spectrum Disorders in Children: A Systematic Review and Quality Assessment

• Published in: Children (Basel) Vol. 9; no. 7; p. 1050
• Main Authors: Amer, Yasser S, Alenezi, Shuliweeh, Bashiri, Fahad A, Alawami, Amel Hussain, Alhazmi, Ayman Shawqi, Aladamawi, Somayyah A, Alnemary, Faisal, Alqahtani, Yasser, Buraik, Maysaa W, AlSuwailem, Saleh S, Akhalifah, Shahad M, Augusta de Souza Pinhel, Marcela, Penner, Melanie, Elmalky, Ahmed M
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 14.07.2022; MDPI
• Subjects: Adaptation; AGREE II instrument; Appraisers; Autism; autism spectrum disorder; Care and treatment; Child & adolescent psychiatry; Clinical medicine; Clinical practice guidelines; Cognitive ability; Comparative analysis; Diagnosis; Evaluation; Language; Laws, regulations and rules; Neurodevelopmental disorders; Pediatric research; Pediatrics; Pervasive developmental disorders; Practice guidelines (Medicine); psychiatry; Systematic Review; Therapists; Saudi Arabia; clinical practice guidelines; pediatrics; quality assessment; AGREE II instrument; psychiatry; autism spectrum disorder; systematic review
• ISSN: 2227-9067; 2227-9067
• DOI: 10.3390/children9071050

Autism spectrum disorder (ASD) is a multifaceted neurodevelopmental disorder requiring multimodal intervention and an army of multidisciplinary teams for a proper rehabilitation plan. Accordingly, multiple practice guidelines have been published for different disciplines. However, systematic evidence to detect and intervene must be updated regularly. Our main objective is to compare and summarize the recommendations made in the clinical practice guidelines (CPGs) for ASD in children released from November 2015 to March 2022. CPGs were subjected to a systematic review. We developed the inclusion and exclusion criteria and health-related questions, then searched and screened for CPGs utilizing bibliographic and CPG databases. Each of the CPGs used in the study were critically evaluated using the Appraisal of Guidelines for REsearch and Evaluation II (AGREE II) instrument. In a realistic comparison table, we summarized the recommendations. Four eligible CPGs were appraised: Australian Autism CRC (ACRC); Ministry of Health New Zealand (NZ); National Institute for Health and Care Excellence (NICE); and Scottish Intercollegiate Guidelines Network, Healthcare Improvement Scotland (SIGN-HIS). The overall assessments of all four CPGs scored greater than 80%; these findings were consistent with the high scores in the six domains of AGREE II, including: (1) scope and purpose, (2) stakeholder involvement, (3) rigor of development, (4) clarity of presentation, (5) applicability, and (6) editorial independence domains. Domain (3) scored 84%, 93%, 86%, and 85%; domain (5) 92%, 89%, 54%, and 85%; and domain (6) 92%, 96%, 88%, and 92% for ACRC, NICE, NZ, and SIGN-HIS, respectively. Overall, there were no serious conflicts between the clinical recommendations of the four CPGs, but some were more comprehensive and elaborative than others. All four assessed evidence-based CPGs demonstrated high methodological quality and relevance for use in practice.